Myeloma 2015 | Emerging monoclonal antibodies for the treatment of multiple myeloma

Rafael Fonseca

At the Myeloma 2015 meeting, Dr Rafael Fonseca (Mayo Clinic, Scottsdale, AZ) discusses novel monoclonal antibodies (mAbs) for the treatment of multiple myeloma. Anti-CD38 mAbs and elotuzumab are showing promising activity in clinical development.

Share this video  
Similar topics